Internal Medicine

Urticaria/Angioedema

Questions discussed in this category

Would you still consider omalizumab for CSU with angioedema in a patient with Factor V Leiden deficiency?

Omalizumab has been reported as a possible provoking factor for venous thromboembolism.

2 Answers available

Related Topics in Internal Medicine